HIGHLIGHTS
- who: Nobendu Mukerjee from the India India have published the article: Recognizing novel drugs against Keap1 in Alzheimer`s disease using machine learning grounded computational studies, in the Journal: (JOURNAL)
- what: The aim of this study was to understand more about Keap1 and its role in Alzheimer`s disease so that the authors could create better treatments.
- how: For the first step of molecular dynamics the authors employed the Swiss PARAM to create the topology file of drugs (Zoete et_al 2011). The authors implemented a 20 ns MD Frontiers in Molecular Neuroscience simulation . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.